These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35589500)

  • 1. Comparison of two polygenic risk scores to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects.
    Cefalù AB; Spina R; Noto D; Rabacchi C; Giammanco A; Simone ML; Brucato F; Scrimali C; Gueli-Alletti MG; Barbagallo CM; Tarugi P; Averna MR
    J Clin Lipidol; 2022; 16(4):530-537. PubMed ID: 35589500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia.
    Rimbert A; Vanhoye X; Coulibaly D; Marrec M; Pichelin M; Charrière S; Peretti N; Valéro R; Wargny M; Carrié A; Lindenbaum P; Deleuze JF; Genin E; Redon R; Rollat-Farnier PA; Goxe D; Degraef G; Marmontel O; Divry E; Bigot-Corbel E; Moulin P; Cariou B; Di Filippo M
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e63-e71. PubMed ID: 33207932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia.
    Magnolo L; Najah M; Fancello T; Di Leo E; Pinotti E; Brini I; Gueddiche NM; Calandra S; Slimene NM; Tarugi P
    Gene; 2013 Jan; 512(1):28-34. PubMed ID: 23043934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.
    Tarugi P; Averna M
    Adv Clin Chem; 2011; 54():81-107. PubMed ID: 21874758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
    Blanco-Vaca F; Martin-Campos JM; Beteta-Vicente Á; Canyelles M; Martínez S; Roig R; Farré N; Julve J; Tondo M
    Atherosclerosis; 2019 Apr; 283():52-60. PubMed ID: 30782561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C.
    Jakubowski B; Shao Y; McNeal C; Xing C; Ahmad Z
    J Clin Lipidol; 2021; 15(5):658-664. PubMed ID: 34340953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotriglyceridemias/hypolipidemias.
    Martínez-Hervás S; Real-Collado JT; Ascaso-Gimilio JF
    Clin Investig Arterioscler; 2021 May; 33 Suppl 2():63-68. PubMed ID: 34006356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene.
    Martín-Morales R; García-Díaz JD; Tarugi P; González-Santos P; Saavedra-Vallejo P; Magnolo L; Mesa-Latorre JM; di Leo E; Valdivielso P
    Gene; 2013 Nov; 531(1):92-6. PubMed ID: 24001780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low cholesterol states: clinical implications and management.
    Gill PK; Hegele RA
    Expert Rev Endocrinol Metab; 2023 May; 18(3):241-253. PubMed ID: 37089071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia.
    Rimbert A; Pichelin M; Lecointe S; Marrec M; Le Scouarnec S; Barrak E; Croyal M; Krempf M; Le Marec H; Redon R; Schott JJ; Magré J; Cariou B
    Atherosclerosis; 2016 Jul; 250():52-6. PubMed ID: 27179706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypobetalipoproteinemia caused by homozygous loss-of-function mutations in PCSK9: A case report.
    Kudo T; Sasaki K; Tada H
    J Clin Lipidol; 2022; 16(5):596-600. PubMed ID: 35931648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
    Fazio S; Minnier J; Shapiro MD; Tsimikas S; Tarugi P; Averna MR; Arca M; Tavori H
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3340-3348. PubMed ID: 28633452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population.
    Yue P; Averna M; Lin X; Schonfeld G
    Hum Mutat; 2006 May; 27(5):460-6. PubMed ID: 16619215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
    Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
    Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic contribution for familial hypercholesterolemia (FH).
    Medeiros AM; Bourbon M
    Curr Opin Lipidol; 2021 Dec; 32(6):392-395. PubMed ID: 34751168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of hypocholesterolemia under study.
    Camacho A; Ariza MJ; Amigó N; Macías Guillén P; Sánchez Chaparro MÁ; Valdivielso P
    Clin Investig Arterioscler; 2023; 35(5):244-247. PubMed ID: 37302939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels.
    Lee CJ; Lee Y; Park S; Kang SM; Jang Y; Lee JH; Lee SH
    PLoS One; 2017; 12(10):e0186446. PubMed ID: 29036232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia.
    Di Costanzo A; Di Leo E; Noto D; Cefalù AB; Minicocci I; Polito L; D'Erasmo L; Cantisani V; Spina R; Tarugi P; Averna M; Arca M
    J Clin Lipidol; 2017; 11(5):1234-1242. PubMed ID: 28733173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
    Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE
    Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.